Drugs for managing diabetic neuropathy are similarly effective, yet the costs of these drugs vary greatly, according to a study in the Annals of Internal Medicine. The researchers conclude that prescribers should consider costs of the drug and other conditions the patient has when deciding what to prescribe. Read more and read the study abstract.